Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372309
Max Phase: Preclinical
Molecular Formula: C51H74N14O12S2
Molecular Weight: 1139.37
Molecule Type: Unknown
Associated Items:
ID: ALA2372309
Max Phase: Preclinical
Molecular Formula: C51H74N14O12S2
Molecular Weight: 1139.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC1(CC)CC(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)CSS1
Standard InChI: InChI=1S/C51H74N14O12S2/c1-4-51(5-2)26-42(69)59-34(24-30-15-17-31(77-3)18-16-30)45(72)62-35(23-29-11-7-6-8-12-29)46(73)60-33(19-20-39(52)66)44(71)63-36(25-40(53)67)47(74)64-37(28-78-79-51)49(76)65-22-10-14-38(65)48(75)61-32(13-9-21-57-50(55)56)43(70)58-27-41(54)68/h6-8,11-12,15-18,32-38H,4-5,9-10,13-14,19-28H2,1-3H3,(H2,52,66)(H2,53,67)(H2,54,68)(H,58,70)(H,59,69)(H,60,73)(H,61,75)(H,62,72)(H,63,71)(H,64,74)(H4,55,56,57)/t32-,33+,34+,35+,36+,37+,38+/m1/s1
Standard InChI Key: XLSRQIOHBNAKAC-GNRRHJDKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1139.37 | Molecular Weight (Monoisotopic): 1138.5052 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):